Skip to main content
Clinical Trials/NCT05446675
NCT05446675CompletedNot Applicable

Single-Center Observational Study With Comparison of Endoscopic Extended-View Totally Extraperitoneal Prosthesis (eTEP) Versus Open Rives-Stoppa Repair as a Treatment of Midline Abdominal Wall Hernias With Rectus Diastasis

AZ Alma1 site in 1 country60 target enrollmentStarted: June 9, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Postoperative pain management

Study Overview

Brief Summary

Observational cohort study (partially retrospective, partially prospective) comparing the endoscopic extended totally extraperitoneal prosthesis (eTEP) repair for midline abdominal hernias to open Rives-Stoppa repair (control).

Detailed Description

See included study protocol. Included patients will be registered to the European Hernia Society (EHS) registry.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Group 1 (eTEP):
  • Participants who underwent an eTEP procedure in the investigators' center
  • Preoperative existence of one or more midline abdominal wall hernias
  • Preoperative existence of rectus abdominis diastasis
  • Group 2 (Rives-Stoppa, control group):
  • Participants who underwent an open Rives-Stoppa (midline repair with sublay mesh) in the investigators' center

Exclusion Criteria

  • Group 1 (eTEP):
  • Preoperative absence of midline abdominal wall hernias
  • Preoperative absence of rectus abdominis diastasis
  • Intraoperative performance of transverse abdominis release (TAR)
  • Intraoperative inguinal hernia repair
  • Group 2 (Rives-Stoppa, control group):
  • Intraoperative performance of transverse abdominis release (TAR)
  • Intraoperative performance of anterior component separation
  • Intraoperative inguinal hernia repair

Outcomes

Primary Outcomes

Postoperative pain management

Time Frame: From the end of surgery (moment of the end of operation) until the date of discharge from the hospital, assessed up to 30 days.

Modality (type, generic name), duration (days), dosage (grams or milligrams) and frequency (times per day) of analgesics administration

Length of hospital stay

Time Frame: From the date of operation until the date of discharge from the hospital, assessed up to 30 days.

Time (days) spent within the hospital

Secondary Outcomes

  • Intraoperative complications(During surgery)
  • Postoperative complications(After discharge until 30 days postoperative)

Investigators

Sponsor
AZ Alma
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials